Finance

Lists
FMS:NYSE
Fresenius Medical Care AG
၂၁.၉၄ US$
-၁.၀၄%
(-၀.၂၃) 1D
၂၁.၉၄ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၉, GMT-၄ ၁၆:၀၀:၀၃  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FMS...
Open
၂၁.၈၈ US$
High
၂၂.၀၁ US$
Low
၂၁.၈၂ US$
Mkt. cap
ဋေ ၁.၁၈ ထ
Avg. vol.
၈.၇၅ သိန်း
Volume
၅.၆၃ သိန်း
Dividend
၃.၉၄%
Quarterly dividend
၀.၂၂ US$
Ex-dividend date
၂၀၂၆ မေ ၂၂
P/E ratio
၁၁.၇၄
52-wk high
၂၇.၄၃ US$
52-wk low
၂၀.၀၂ US$
EPS
၁.၈၇ US$
Beta
၀.၇၇
Shares outstanding
၅၃.၇၁ ကုဋေ
No. of employees
၁ သိန်း
Open
၂၁.၈၈ US$
High
၂၂.၀၁ US$
Low
၂၁.၈၂ US$
Mkt. cap
ဋေ ၁.၁၈ ထ
Avg. vol.
၈.၇၅ သိန်း
Volume
၅.၆၃ သိန်း
Dividend
၃.၉၄%
Quarterly dividend
၀.၂၂ US$
Ex-dividend date
၂၀၂၆ မေ ၂၂
P/E ratio
၁၁.၇၄
52-wk high
၂၇.၄၃ US$
52-wk low
၂၀.၀၂ US$
EPS
၁.၈၇ US$
Beta
၀.၇၇
Shares outstanding
၅၃.၇၁ ကုဋေ
No. of employees
၁ သိန်း
News stories
From web sources and news partners
TradingView
TradingView
·
ပြီးခဲ့သည့် ၇ နာရီ
Fresenius Medical Care AG (FME) Discloses Management Share Acquisition
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၅ နာရီ
JPMorgan keeps Sell target for Fresenius Medical Care stock at EUR 32.30
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၆ နာရီ
FMC stock pre-market at EUR 39.30: dialysis care provider
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees၁.၀၇ သိန်း
Founded၁၉၉၆
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 3 analysts giving stock ratings to FMS in the past 3 months
Sell
Buy
0
Hold
2
Sell
1
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for FMS in the last 3 months.
Highest
Current ၂၁.၉၄ US$
၂၅.၈၀ US$ (+၁၇.၅၉%)
Average
၂၃.၂၃ US$ (+၅.၈၈%)
Lowest
၁၉.၉၀ US$ (-၉.၃၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
David S Macdonald
Truist Financial
Hold
Maintained
၂၄.၀၀ US$
+၉.၄%
10/12/2026
Susannah Ludwig
Bernstein
Hold
Maintained
၂၅.၈၀ US$
+၁၇.၆%
08/06/2026
Unknown Analyst
Bernstein
Hold
Maintained
၂၅.၈၀ US$
+၁၇.၆%
08/06/2026
Hugo Solvet
Exane BNP Paribas
Sell
Downgraded
၁၉.၉၀ US$
-၉.၃%
07/28/2026
Marianne Bulot
Bank of America Securities
Sell
Downgraded
၂၂.၀၀ US$
+၀.၃%
10/15/2025
Last report
၂၀၂၆ ဩ ၄
Fiscal period
Q2 2026
၀.၅၆ € / ၀.၅၀ €
+၁၃.၁၁%beat
Revenue / Est. (EUR)
၄၈၆.၀၆ ဋေ / ၄၇၈.၉၉ ဋေ
+၁.၄၇%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၄၈၈.၄၈ ဋေ
၅၀၆.၉၆ ဋေ
၄၆၁.၂၁ ဋေ
၄၈၆.၀၆ ဋေ
Cost of goods sold
၃၆၄.၂၆ ဋေ
၃၆၈.၁၂ ဋေ
၃၄၃.၂၇ ဋေ
၃၅၅.၀၆ ဋေ
Cost of revenue
၃၆၄.၂၆ ဋေ
၃၆၈.၁၂ ဋေ
၃၄၃.၂၇ ဋေ
၃၅၅.၀၆ ဋေ
Research and development expenses
၃.၇၇ ကုဋေ
၃.၈၆ ကုဋေ
၃.၈၃ ကုဋေ
၃.၉၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၇၀.၅၄ ကုဋေ
၇၈.၄၆ ကုဋေ
၇၄.၈၉ ကုဋေ
၇၃.၆၀ ကုဋေ
Operating expense
၇၄.၀၅ ကုဋေ
၇၉.၆၃ ကုဋေ
၈၀.၃၉ ကုဋေ
၇၈.၆၄ ကုဋေ
Total operating expenses
၄၃၈.၃၁ ဋေ
၄၄၇.၇၆ ဋေ
၄၂၃.၆၆ ဋေ
၄၃၃.၆၉ ဋေ
Operating income
၅၀.၁၇ ကုဋေ
၅၉.၂၀ ကုဋေ
၃၇.၅၆ ကုဋေ
၅၂.၃၆ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၄၀.၂၆ ကုဋေ
၅၀.၈၅ ကုဋေ
၂၀.၇၅ ကုဋေ
၃၈.၃၀ ကုဋေ
EBT excluding unusual items
၄၆.၂၇ ကုဋေ
၅၄.၁၈ ကုဋေ
၃၃.၄၄ ကုဋေ
၃၉.၉၂ ကုဋေ
Income tax expense
၇.၅၂ ကုဋေ
၁၀.၆၄ ကုဋေ
၄.၂၈ ကုဋေ
၈.၉၈ ကုဋေ
Effective tax rate
၁၈.၆၉%
၂၀.၉၃%
၂၀.၆၀%
၂၃.၄၅%
Other operating expenses
-၂.၆၉ သန်း
-၂.၆၉ ကုဋေ
၁.၆၇ ကုဋေ
၁.၀၇ ကုဋေ
Net income
၂၇.၄၈ ကုဋေ
၃၂.၇၁ ကုဋေ
၁၁.၇၅ ကုဋေ
၂၁.၈၄ ကုဋေ
Net profit margin
၅.၆၃%
၆.၄၅%
၂.၅၅%
၄.၄၉%
Earnings per share
၁.၁၀
၁.၄၄
၀.၉၁
၀.၅၆
Interest and investment income
၁.၉၂ ကုဋေ
၁.၃၆ ကုဋေ
၁.၄၆ ကုဋေ
၁.၄၇ ကုဋေ
Interest expense
-၉.၃၁ ကုဋေ
-၉.၉၀ ကုဋေ
-၉.၃၃ ကုဋေ
-၉.၇၆ ကုဋေ
Net interest expenses
-၇.၃၉ ကုဋေ
-၈.၅၄ ကုဋေ
-၇.၈၇ ကုဋေ
-၈.၂၉ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၈၅.၃၆ ကုဋေ
၇၈.၀၂ ကုဋေ
၇၂.၇၈ ကုဋေ
၈၇.၉၄ ကုဋေ
Gain or loss from assets sale
၅.၀၃ ကုဋေ
၁.၇၉ ကုဋေ
၈.၇၇ သန်း
-၄.၀၉ သန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ